Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
The US Food and Drug Administration (FDA) authorized the Applied Biosystems TaqPath COVID-19 Kit for emergency use just days after the World Health Organization (WHO) declared COVID-19 a global pandemic and later received the CE mark in Europe. Since then, Thermo Fisher Scientific has continued to grow and enhance the TaqPath testing portfolio, enabling an uninterrupted product supply to support your lab’s evolving needs—now and in the future.
“Flurona” is a co-infection of COVID-19 and the flu. Get the facts.
Note: This tool is best viewed in Chrome, Firefox or Safari Browsers. Learn more ›
Testing use case | Testing solution |
---|---|
Potential early identification of Omicron (B.1.1.529)* | TaqPath COVID-19 Combo Kit |
Flu season response | TaqPath COVID-19, Flu A, Flu B Combo Kit |
Fast direct from saliva + RNase P and mutation resilient | TaqPath COVID-19 Fast PCR Combo Kit 2.0 |
RNase P control needed with nasal swabs and mutation resilient | TaqPath COVID-19 RNase P Combo Kit 2.0 |
Pooling for lower cost/population testing in areas with low incidence rates | TaqPath COVID-19 Pooling Kit |
Automation for lower cost/higher throughput/flexible testing | TaqPath COVID-19 HT Kit |
We are a trusted partner during this time, enabling unprecedented testing demand and providing accurate, proven results.
TaqPath COVID-19 Combo Kit, Amplitude Solution, TaqPath COVID-19, Flu A, Flu B Combo Kit, TaqPath COVID-19 Pooling kit, TaqPath COVID-19 Fast PCR Combo Kit 2.0, and TaqPath COVID-19 RNase P Combo Kit 2.0: For Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.